animal free il 15 protein Search Results


recombinant human il 2  (R&D Systems)
93
R&D Systems recombinant human il 2
Recombinant Human Il 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human il 2/product/R&D Systems
Average 93 stars, based on 1 article reviews
recombinant human il 2 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
interleukin 8 il 8  (MedChemExpress)
93
MedChemExpress interleukin 8 il 8
Anti-IL-8 and anti-VEGFA antibodies partially reverse the ability of MMP28 to promote the migration of TAMs and the polarization of M2 TAMs. A CM from MMP28-overexpressing pancreatic cancer cells was treated with an anti-IL-8 neutralizing antibody (5 μg/mL) or an anti-VEGFA neutralizing antibody (1 μg/mL). The migration level of TAMs was determined by the Transwell migration experiment. Scale bar, 100 μm. B qRT-PCR determination of CD86 and CD163 mRNA expression levels in TAMs cocultured with Vector group of pancreatic cancer cells transfected with empty vector virus, TAMs cocultured with OE-MMP28 cell group, TAMs cocultured with the OE-MMP28 + IgG cell group, TAMs cocultured with OE-MMP28 + Anti-IL-8 cell group, and TAMs cocultured with OE-MMP28 + Anti-VEGFA cell group. C The expression levels of the TAM markers CD86 and CD163 in different coculture groups were determined by immunofluorescence staining. Scale bar, 50 μm. D The proportions of CD11b + CD86 + TAMs and CD11b + CD163 + TAMs in different coculture groups were analysed by flow cytometry. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001
Interleukin 8 Il 8, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/interleukin 8 il 8/product/MedChemExpress
Average 93 stars, based on 1 article reviews
interleukin 8 il 8 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
ilb  (R&D Systems)
90
R&D Systems ilb
Anti-IL-8 and anti-VEGFA antibodies partially reverse the ability of MMP28 to promote the migration of TAMs and the polarization of M2 TAMs. A CM from MMP28-overexpressing pancreatic cancer cells was treated with an anti-IL-8 neutralizing antibody (5 μg/mL) or an anti-VEGFA neutralizing antibody (1 μg/mL). The migration level of TAMs was determined by the Transwell migration experiment. Scale bar, 100 μm. B qRT-PCR determination of CD86 and CD163 mRNA expression levels in TAMs cocultured with Vector group of pancreatic cancer cells transfected with empty vector virus, TAMs cocultured with OE-MMP28 cell group, TAMs cocultured with the OE-MMP28 + IgG cell group, TAMs cocultured with OE-MMP28 + Anti-IL-8 cell group, and TAMs cocultured with OE-MMP28 + Anti-VEGFA cell group. C The expression levels of the TAM markers CD86 and CD163 in different coculture groups were determined by immunofluorescence staining. Scale bar, 50 μm. D The proportions of CD11b + CD86 + TAMs and CD11b + CD163 + TAMs in different coculture groups were analysed by flow cytometry. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001
Ilb, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ilb/product/R&D Systems
Average 90 stars, based on 1 article reviews
ilb - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
il 6 afl206  (R&D Systems)
90
R&D Systems il 6 afl206
Anti-IL-8 and anti-VEGFA antibodies partially reverse the ability of MMP28 to promote the migration of TAMs and the polarization of M2 TAMs. A CM from MMP28-overexpressing pancreatic cancer cells was treated with an anti-IL-8 neutralizing antibody (5 μg/mL) or an anti-VEGFA neutralizing antibody (1 μg/mL). The migration level of TAMs was determined by the Transwell migration experiment. Scale bar, 100 μm. B qRT-PCR determination of CD86 and CD163 mRNA expression levels in TAMs cocultured with Vector group of pancreatic cancer cells transfected with empty vector virus, TAMs cocultured with OE-MMP28 cell group, TAMs cocultured with the OE-MMP28 + IgG cell group, TAMs cocultured with OE-MMP28 + Anti-IL-8 cell group, and TAMs cocultured with OE-MMP28 + Anti-VEGFA cell group. C The expression levels of the TAM markers CD86 and CD163 in different coculture groups were determined by immunofluorescence staining. Scale bar, 50 μm. D The proportions of CD11b + CD86 + TAMs and CD11b + CD163 + TAMs in different coculture groups were analysed by flow cytometry. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001
Il 6 Afl206, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 6 afl206/product/R&D Systems
Average 90 stars, based on 1 article reviews
il 6 afl206 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
animal free il 6  (R&D Systems)
86
R&D Systems animal free il 6
Anti-IL-8 and anti-VEGFA antibodies partially reverse the ability of MMP28 to promote the migration of TAMs and the polarization of M2 TAMs. A CM from MMP28-overexpressing pancreatic cancer cells was treated with an anti-IL-8 neutralizing antibody (5 μg/mL) or an anti-VEGFA neutralizing antibody (1 μg/mL). The migration level of TAMs was determined by the Transwell migration experiment. Scale bar, 100 μm. B qRT-PCR determination of CD86 and CD163 mRNA expression levels in TAMs cocultured with Vector group of pancreatic cancer cells transfected with empty vector virus, TAMs cocultured with OE-MMP28 cell group, TAMs cocultured with the OE-MMP28 + IgG cell group, TAMs cocultured with OE-MMP28 + Anti-IL-8 cell group, and TAMs cocultured with OE-MMP28 + Anti-VEGFA cell group. C The expression levels of the TAM markers CD86 and CD163 in different coculture groups were determined by immunofluorescence staining. Scale bar, 50 μm. D The proportions of CD11b + CD86 + TAMs and CD11b + CD163 + TAMs in different coculture groups were analysed by flow cytometry. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001
Animal Free Il 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/animal free il 6/product/R&D Systems
Average 86 stars, based on 1 article reviews
animal free il 6 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier
recombinant proteins animal  (Proteintech)
91
Proteintech recombinant proteins animal
Anti-IL-8 and anti-VEGFA antibodies partially reverse the ability of MMP28 to promote the migration of TAMs and the polarization of M2 TAMs. A CM from MMP28-overexpressing pancreatic cancer cells was treated with an anti-IL-8 neutralizing antibody (5 μg/mL) or an anti-VEGFA neutralizing antibody (1 μg/mL). The migration level of TAMs was determined by the Transwell migration experiment. Scale bar, 100 μm. B qRT-PCR determination of CD86 and CD163 mRNA expression levels in TAMs cocultured with Vector group of pancreatic cancer cells transfected with empty vector virus, TAMs cocultured with OE-MMP28 cell group, TAMs cocultured with the OE-MMP28 + IgG cell group, TAMs cocultured with OE-MMP28 + Anti-IL-8 cell group, and TAMs cocultured with OE-MMP28 + Anti-VEGFA cell group. C The expression levels of the TAM markers CD86 and CD163 in different coculture groups were determined by immunofluorescence staining. Scale bar, 50 μm. D The proportions of CD11b + CD86 + TAMs and CD11b + CD163 + TAMs in different coculture groups were analysed by flow cytometry. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001
Recombinant Proteins Animal, supplied by Proteintech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant proteins animal/product/Proteintech
Average 91 stars, based on 1 article reviews
recombinant proteins animal - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier
recombinant human il-7 protein, animal-free  (Bio-Techne corporation)
90
Bio-Techne corporation recombinant human il-7 protein, animal-free
Anti-IL-8 and anti-VEGFA antibodies partially reverse the ability of MMP28 to promote the migration of TAMs and the polarization of M2 TAMs. A CM from MMP28-overexpressing pancreatic cancer cells was treated with an anti-IL-8 neutralizing antibody (5 μg/mL) or an anti-VEGFA neutralizing antibody (1 μg/mL). The migration level of TAMs was determined by the Transwell migration experiment. Scale bar, 100 μm. B qRT-PCR determination of CD86 and CD163 mRNA expression levels in TAMs cocultured with Vector group of pancreatic cancer cells transfected with empty vector virus, TAMs cocultured with OE-MMP28 cell group, TAMs cocultured with the OE-MMP28 + IgG cell group, TAMs cocultured with OE-MMP28 + Anti-IL-8 cell group, and TAMs cocultured with OE-MMP28 + Anti-VEGFA cell group. C The expression levels of the TAM markers CD86 and CD163 in different coculture groups were determined by immunofluorescence staining. Scale bar, 50 μm. D The proportions of CD11b + CD86 + TAMs and CD11b + CD163 + TAMs in different coculture groups were analysed by flow cytometry. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001
Recombinant Human Il 7 Protein, Animal Free, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human il-7 protein, animal-free/product/Bio-Techne corporation
Average 90 stars, based on 1 article reviews
recombinant human il-7 protein, animal-free - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Anti-IL-8 and anti-VEGFA antibodies partially reverse the ability of MMP28 to promote the migration of TAMs and the polarization of M2 TAMs. A CM from MMP28-overexpressing pancreatic cancer cells was treated with an anti-IL-8 neutralizing antibody (5 μg/mL) or an anti-VEGFA neutralizing antibody (1 μg/mL). The migration level of TAMs was determined by the Transwell migration experiment. Scale bar, 100 μm. B qRT-PCR determination of CD86 and CD163 mRNA expression levels in TAMs cocultured with Vector group of pancreatic cancer cells transfected with empty vector virus, TAMs cocultured with OE-MMP28 cell group, TAMs cocultured with the OE-MMP28 + IgG cell group, TAMs cocultured with OE-MMP28 + Anti-IL-8 cell group, and TAMs cocultured with OE-MMP28 + Anti-VEGFA cell group. C The expression levels of the TAM markers CD86 and CD163 in different coculture groups were determined by immunofluorescence staining. Scale bar, 50 μm. D The proportions of CD11b + CD86 + TAMs and CD11b + CD163 + TAMs in different coculture groups were analysed by flow cytometry. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: MMP28 recruits M2-type tumor-associated macrophages through MAPK/JNK signaling pathway-dependent cytokine secretion to promote the malignant progression of pancreatic cancer

doi: 10.1186/s13046-025-03321-x

Figure Lengend Snippet: Anti-IL-8 and anti-VEGFA antibodies partially reverse the ability of MMP28 to promote the migration of TAMs and the polarization of M2 TAMs. A CM from MMP28-overexpressing pancreatic cancer cells was treated with an anti-IL-8 neutralizing antibody (5 μg/mL) or an anti-VEGFA neutralizing antibody (1 μg/mL). The migration level of TAMs was determined by the Transwell migration experiment. Scale bar, 100 μm. B qRT-PCR determination of CD86 and CD163 mRNA expression levels in TAMs cocultured with Vector group of pancreatic cancer cells transfected with empty vector virus, TAMs cocultured with OE-MMP28 cell group, TAMs cocultured with the OE-MMP28 + IgG cell group, TAMs cocultured with OE-MMP28 + Anti-IL-8 cell group, and TAMs cocultured with OE-MMP28 + Anti-VEGFA cell group. C The expression levels of the TAM markers CD86 and CD163 in different coculture groups were determined by immunofluorescence staining. Scale bar, 50 μm. D The proportions of CD11b + CD86 + TAMs and CD11b + CD163 + TAMs in different coculture groups were analysed by flow cytometry. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001

Article Snippet: When the tumors reached a volume of at least 80 mm 3 one week post-injection, the treatment groups received the following treatments: PBS, Clodronate Liposomes (200 μL/mouse, YEASEN), the JNK inhibitor SP600125 (15 mg/kg/mouse, MCE), the interleukin-8 (IL-8)-neutralizing antibody MAB208-SP (10 μg/mouse, R&D Systems), or vascular endothelial growth factor A (VEGFA)-neutralizing antibody MAB293-SP (1 μg/mouse, R&D Systems).

Techniques: Migration, Quantitative RT-PCR, Expressing, Plasmid Preparation, Transfection, Virus, Immunofluorescence, Staining, Flow Cytometry

MMP28 enhances M2 TAM infiltration and promotes pancreatic cancer growth in vivo. A Effects of the administration of Clodronate Liposomes, the JNK inhibitor SP600125, the anti-IL-8 neutralizing antibody MAB208-SP, and the anti-VEGFA neutralizing antibody MAB293-SP on subcutaneous tumors in nude mice in the experimental group. B - C Representative images of subcutaneous tumors in nude mice detected with fluorescein potassium salt and the fluorescence quantitative analysis. After the tumor volume reached at least 80mm 3 , PBS, Clodronate Liposomes (200 μg), the JNK inhibitor SP600125 (15 mg/kg), the anti-IL-8 antibody MAB208-SP (10 μg), and the anti-VEGFA antibody MAB293-SP (1 μg) were injected intraperitoneally into the nude mice. D Representative images of subcutaneous xenograft tumors (5 mice per group). E The volume of the tumor was measured every four days. F Tumor weight in both groups. G Representative images of MMP28 expression levels in xenograft tumors from the Vector and OE-MMP28 groups as determined by immunohistochemical staining. Scale bar, 50 μm. H Immunohistochemical staining detection of expression of Ki67 and CD86 + and CD163 + TAM infiltration in xenograft tumors in the Vector group, OE-MMP28 group, OE-MMP28 + SP600125 group, OE-MMP28 + MAB208-SP group, OE-MMP28 + MAB293-SP group, and Vector + Clodronate Liposomes group

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: MMP28 recruits M2-type tumor-associated macrophages through MAPK/JNK signaling pathway-dependent cytokine secretion to promote the malignant progression of pancreatic cancer

doi: 10.1186/s13046-025-03321-x

Figure Lengend Snippet: MMP28 enhances M2 TAM infiltration and promotes pancreatic cancer growth in vivo. A Effects of the administration of Clodronate Liposomes, the JNK inhibitor SP600125, the anti-IL-8 neutralizing antibody MAB208-SP, and the anti-VEGFA neutralizing antibody MAB293-SP on subcutaneous tumors in nude mice in the experimental group. B - C Representative images of subcutaneous tumors in nude mice detected with fluorescein potassium salt and the fluorescence quantitative analysis. After the tumor volume reached at least 80mm 3 , PBS, Clodronate Liposomes (200 μg), the JNK inhibitor SP600125 (15 mg/kg), the anti-IL-8 antibody MAB208-SP (10 μg), and the anti-VEGFA antibody MAB293-SP (1 μg) were injected intraperitoneally into the nude mice. D Representative images of subcutaneous xenograft tumors (5 mice per group). E The volume of the tumor was measured every four days. F Tumor weight in both groups. G Representative images of MMP28 expression levels in xenograft tumors from the Vector and OE-MMP28 groups as determined by immunohistochemical staining. Scale bar, 50 μm. H Immunohistochemical staining detection of expression of Ki67 and CD86 + and CD163 + TAM infiltration in xenograft tumors in the Vector group, OE-MMP28 group, OE-MMP28 + SP600125 group, OE-MMP28 + MAB208-SP group, OE-MMP28 + MAB293-SP group, and Vector + Clodronate Liposomes group

Article Snippet: When the tumors reached a volume of at least 80 mm 3 one week post-injection, the treatment groups received the following treatments: PBS, Clodronate Liposomes (200 μL/mouse, YEASEN), the JNK inhibitor SP600125 (15 mg/kg/mouse, MCE), the interleukin-8 (IL-8)-neutralizing antibody MAB208-SP (10 μg/mouse, R&D Systems), or vascular endothelial growth factor A (VEGFA)-neutralizing antibody MAB293-SP (1 μg/mouse, R&D Systems).

Techniques: In Vivo, Liposomes, Fluorescence, Injection, Expressing, Plasmid Preparation, Immunohistochemical staining, Staining